Abiopharma

🔍 Gilde Healthcare Holding B.V. (Executive)

Company: SHOULDER INNOVATIONS, INC. (SI)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Sold 28,245 shares of Common Stock at $23.36 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 2,352,237.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 20,034 shares of Common Stock at $22.73 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 2,332,203.00 | transaction_form_type: 4 | Footnotes: F3, F2, F2

Footnotes:

• F1: This figure is the weighted average sales price of multiple trades ranging from $23.00 to $23.73 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, Shoulder Innovations, Inc. or any security holder of Shoulder Innovations, Inc. full information about the number of shares sold at each separate price upon request.
• F2: Held directly by Cooperatieve Gilde Healthcare V U.A. ("Gilde"). Gilde Healthcare V Management B.V. is the managing director of Gilde and has sole voting and dispositive power with respect to the shares held by Gilde. Gilde Healthcare V Management B.V. is owned by Gilde Healthcare Holding B.V. The managing partners of Gilde Healthcare Holding B.V. are Manapouri B.V. (of which Edwin de Graaf is the owner and managing director) and Martemanshurk B.V. (of which Pieter van der Meer is the owner and managing director). Geoff Pardo is a partner at Gilde and may be deemed to share voting and dispositive power with respect to the shares held of record by Gilde. Mr. Pardo disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares.
• F3: This figure is the weighted average sales price of multiple trades ranging from $22.60 to $23.00 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, Shoulder Innovations, Inc. or any security holder of Shoulder Innovations, Inc. full information about the number of shares sold at each separate price upon request.